US2005186189A1PendingUtilityA1
Novel microorganism strain GM-020 of Lactobacillus rhamnosus and its use for treating obesity
Est. expiryFeb 19, 2024(expired)· nominal 20-yr term from priority
A61K 36/07C12R 2001/225C12N 1/205A61K 35/747C12N 1/20
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides an isolated microorganism strain, Lactobacillus rhamnosus GM-020, which is found to be effective in treating obesity and a complication thereof. The use of the Lactobacillus rhamnosus GM-020 in treating obesity and a complication thereof is also provided.
Claims
exact text as granted — not AI-modified1 - 2 . (canceled)
3 . A method for treating obesity or a complication thereof in a subject comprising: administrating to said subject a composition comprising an isolated microorganism of the strain Lactobacillus rhamnosus GM-020, deposited at the China Center for Type Culture Collection under CCTCC No.: CCTCC M 203098.
4 . The method according to claim 3 , wherein the composition further comprises Auricularia polytricha.
5 . The method according to claim 3 , wherein the complication is selected from the group consisting of hypercholesterolemia, atherosclerosis and coronary heart disease.
6 . A method for treating obesity or a complication thereof in a subject comprising administrating to said subject a composition comprising an isolated microorganism of the strain Lactobacillus rhamnosus GM-020, deposited at the China Center for Type Culture Collection under CCTCC No.: CCTCC M 203098 and Auricularia polytricha.
7 . The method according to claim 6 , wherein the complication is selected from the group consisting of hypercholesterolemia, atherosclerosis, coronary heart disease, fatty liver, and diabetes mellitus.
8 - 12 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.